Pediatric Studies: Must Sponsors Meet Every Detail Of US FDA Request To Get Exclusivity?

In suit against FDA, Amgen argues it provided sufficient data to obtain exclusivity for Sensipar but agency says too few patients were included in one study; court ruled against FDA in similar 2001 dispute.